HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery.

AbstractPURPOSE:
The impact of weight loss on obesity-related colorectal cancer (CRC) risk is not well defined. Previous studies have suggested that Roux-en-Y gastric bypass (RYGB) surgery may have an unexpected adverse impact on CRC risk. This study aimed to investigate the impact of RYGB on biomarkers of CRC risk.
MATERIALS AND METHODS:
Rectal mucosal biopsies and blood were obtained from patients undergoing RYGB (n = 22) and non-obese control participants (n = 20) at baseline and at a median of 6.5 months after surgery. Markers of systemic inflammation and glucose homeostasis were measured. Expression of pro-inflammatory genes and proto-oncogenes in the rectal mucosa was quantified using qPCR. Crypt cell proliferation state of the rectal mucosa was assessed by counting mitotic figures in whole micro-dissected crypts.
RESULTS:
At 6.5 months post-surgery, participants had lost 29 kg body mass and showed improvements in markers of glucose homeostasis and in systemic inflammation. Expression of pro-inflammatory genes in the rectal mucosa did not increase and COX-1 expression fell significantly (P = 0.019). The mean number of mitoses per crypt decreased from 6.5 to 4.3 (P = 0.028) after RYGB.
CONCLUSION:
RYGB in obese adults led to lower rectal crypt cell proliferation, reduced systemic and mucosal markers of inflammation and improvements in glucose regulation. These consistent findings of reduced markers of tumourigenic potential suggest that surgically induced weight loss may lower CRC risk.
AuthorsSorena Afshar, Fiona Malcomson, Seamus B Kelly, Keith Seymour, Sean Woodcock, John C Mathers
JournalObesity surgery (Obes Surg) Vol. 28 Issue 4 Pg. 945-954 (04 2018) ISSN: 1708-0428 [Electronic] United States
PMID28990150 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
Topics
  • Adolescent
  • Adult
  • Aged
  • Biomarkers (analysis, blood, metabolism)
  • Biopsy
  • Case-Control Studies
  • Colorectal Neoplasms (blood, diagnosis, etiology, pathology)
  • Down-Regulation
  • Female
  • Follow-Up Studies
  • Gastric Bypass
  • Humans
  • Inflammation (blood)
  • Intestinal Mucosa (pathology)
  • Male
  • Middle Aged
  • Obesity, Morbid (blood, complications, pathology, surgery)
  • Rectum (pathology)
  • Risk Factors
  • Time Factors
  • Weight Loss (physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: